197 related articles for article (PubMed ID: 27104)
1. Human platelet MAO in drug-free and medicated schizophrenic patients.
Friedhoff AJ; Miller JC; Weisenfreund J
Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
[TBL] [Abstract][Full Text] [Related]
3. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
Marcolin MA; Davis JM
Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
[TBL] [Abstract][Full Text] [Related]
4. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
Takahashi S; Yamane H; Tani N
Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
[TBL] [Abstract][Full Text] [Related]
5. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
6. Poor outcome and low platelet MAO activity in chronic schizophrenia.
Bierer L; Docherty JP; Young JG; Giller E; Cohen D
Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
[TBL] [Abstract][Full Text] [Related]
7. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
[TBL] [Abstract][Full Text] [Related]
8. Platelet monoamine oxidase in chronic schizophrenic patients.
Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
[TBL] [Abstract][Full Text] [Related]
9. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
Mann J; Thomas KM
Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
[TBL] [Abstract][Full Text] [Related]
13. Platelet monoamine oxidase activity in schizophrenic patients.
Becker RE; Shaskan EG
Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
[TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase activity in schizophrenia: a review of the data.
Wyatt RJ; Potkin SG; Murphy DL
Am J Psychiatry; 1979 Apr; 136(4A):377-85. PubMed ID: 371419
[TBL] [Abstract][Full Text] [Related]
15. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
Sullivan J; Stanfield CN; Dackis C
Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
[TBL] [Abstract][Full Text] [Related]
16. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
[TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity and schizophrenic prognosis.
Gruen R; Baron M; Levitt M; Asnis L
Am J Psychiatry; 1982 Feb; 139(2):240-1. PubMed ID: 7055302
[No Abstract] [Full Text] [Related]
18. Platelet monoamine oxidase activity in acute schizophrenia.
Carpenter WT; Murphy DL; Wyatt RJ
Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
[TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase activity in neuroleptic-naive schizophrenic patients: lack of influence of chronic perphenazine treatment.
Spivak B; Kosower N; Zipser Y; Shreiber-Schul N; Apter A; Tyano S; Weizman A
Clin Neuropharmacol; 1994 Feb; 17(1):83-8. PubMed ID: 8149362
[TBL] [Abstract][Full Text] [Related]
20. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
